Peter Evan Harwin, Director: Spyre Therapeutics SYRE Sell · Filed 06/23

Trade details

Type: Insider sale
Amount: $399,658,667.11
Shares · price: 4,684,781 sh · $85.31 a share
Held after: 0 sh
Stock: Spyre Therapeutics SYRE
Person: Peter Evan HarwinDirector
Trade date: 26/06/23
Filed: 26/06/23
Days to filing: 0 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Peter Evan Harwin's recent trades

Peter Evan HarwinDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
Peter Evan HarwinDirector
SellApogee Therapeutics
Sell
Apogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
Peter Evan HarwinDirector
BuyCrescent Biopharma
Buy
Crescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
Peter Evan HarwinDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$6M
316,219 sh
$6M
Filed 25/10/09
Traded 25/10/07
Peter Evan HarwinDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$5.1M
300,000 sh
$5.1M
Filed 24/09/17
Traded 24/09/16